why choose us

Clinical Trials Search

Showing 17,320 of 132,963 result(s)
Comparative Analysis of Spinal Anesthesia Versus General Anesthesia for vNOTES

Status: Completed

Condition: Anesthesia

Interventions: Fentanyl (1µg;kg) and midazolam are administered intravenously prior to puncture.
Using an aseptic technique, the subarachnoid space is punc

Date: 2022-12-14

Evaluation of Clinical Tool to Improve Adherence to Ventilator Management at UM

Status: NOT_YET_RECRUITING

Condition: Respiratory Therapy

Interventions: RRT's will be given the RT Assistant to use during a regular ICU shift to make patient care decisions.

Date: 2022-12-14

Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention

Status: Completed

Condition: Gynecologic Cancer

Interventions: Option to access no-cost telegenetic counseling and genetic testing

Date: 2022-12-14

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Participants With Aggressive B-cell Non-Hodgkin Lymphomas

Status: Completed

Condition: B-cell Non-Hodgkins Lymphoma (B-NHL)

Interventions: Odronextamab will be administered by IV infusion

Date: 2022-12-14

Cryoablation for Monomorphic Ventricular Tachycardia Early Feasibility Study (EFS)

Status: Completed

Condition: Sustained VT

Interventions: ablation procedure for VT using the investigational device

Date: 2022-12-14

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years

Status: Completed

Condition: Hematologic Diseases

Interventions: Different strength of GSK4172239D will be administered in different cohorts.

Date: 2022-12-13

A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants

Status: COMPLETED

Condition: Healthy Participants

Interventions: Specified dose on specified days

Date: 2022-12-13

CARv3-TEAM-E T Cells in Glioblastoma

Status: Completed

Condition: Glioblastoma

Interventions: Autologous T lymphocyte population that contains cells transduced ex-vivo with a CARv3-TEAM-E lentiviral vector encoding a chimeric antigen receptor (

Date: 2022-12-13